All studies.
Explore the evidence.

Oral semaglutide 25 mg in adults with overweight or obesity

Once-weekly semaglutide 7.2 mg in adults with obesity

Tirzepatide for obesity treatment and diabetes prevention

Tirzepatide as compared with semaglutide for treatment of obesity

Systematic review of tirzepatide for adults living with obesity

Oxytocin for social cognition and psychiatric symptoms: systematic review

GLP-1 and dual incretin agonists in obesity: 2025 state-of-the-art review

Semaglutide weight and anthropometric outcomes in obesity over long-term follow-up

Tesamorelin meta-analysis in HIV-associated lipodystrophy

Semaglutide vs tirzepatide and modern obesity pharmacotherapy: comparative review

Tesamorelin, sermorelin, and GHRH analogs: comparative endocrine review

Retatrutide triple hormone receptor agonist for obesity

Retatrutide triple agonist obesity trial

Retatrutide metabolic outcomes in obesity study

MOTS-c functionally prevents metabolic disorders: a review

MOTS-c: a promising mitochondrial-derived peptide for therapeutic exploitation

Semaglutide and cardiovascular outcomes in obesity without diabetes

Tirzepatide once weekly for treatment of obesity in patients with type 2 diabetes

Mitochondrial peptide SLU-PP-332 increases metabolic rate in animal models

SLU-PP-332 metabolic peptide activates mitochondrial respiration

Tirzepatide once weekly for obesity treatment (SURMOUNT-1 trial)

Tirzepatide dual incretin therapy for obesity

KPV and melanocortin-derived tripeptides in inflammatory disease

Semaglutide treatment for obesity in adults (STEP 1 trial)

Semaglutide weight loss outcomes in STEP-1 trial

Tirzepatide glycemic control trial in type 2 diabetes

Stable gastric pentadecapeptide BPC-157 and wound healing

MOTS-c is an exercise-induced, mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

Semax in neurocognitive and ischemic models: mechanistic review

MOTS-c and exercise adaptation in skeletal muscle metabolism

Thymosin alpha 1 and host immune recovery in infectious disease

Thymosin alpha 1 in immune regulation and clinical application

LL-37 in inflammation, autoimmunity, and tissue repair

Bremelanotide in women with hypoactive sexual desire disorder: pooled phase 3 analysis

Bremelanotide clinical pharmacology and efficacy review

Mitochondrial peptides regulate aging and metabolic stress pathways

PT-141 (bremelanotide) for treatment of hypoactive sexual desire disorder

Growth hormone therapy and metabolic effects

Growth hormone physiology and systemic effects

Critical review of BPC-157 for soft tissue healing and functional restoration

BPC-157 review of soft tissue healing applications

Peptide drugs are increasingly used in metabolic and endocrine disease

Bremelanotide improved sexual desire in women with HSDD

PE-22-28 peptide modulates serotonin pathways in depression models

PE-22-28 peptide exhibits antidepressant activity in rodent models

LL-37 antimicrobial peptide activity in innate immunity

MOTS-c protects against metabolic stress in mice

Semaglutide cardiovascular outcomes in diabetes

Thymosin alpha 1 as an immunomodulatory peptide in infection and malignancy

Peptide therapeutics represent a rapidly expanding pharmaceutical class

SS-31 mitochondrial peptide improves skeletal muscle performance

LL-37 and host defense peptides in innate immunity

GLP-1 receptor agonists and cardiovascular-metabolic benefits

NAD+ metabolism and mitochondrial function in age-related decline

Long-term tesamorelin therapy and body composition

MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism

Peptide regulation of lifespan and age-related pathways: evidence for epitalon

NAD+ repletion improves mitochondrial and stem cell function in aging mice

NAD+ metabolism in aging and disease

Oxytocin pathways in social bonding and affective behavior

SS-31 improves mitochondrial energetics in aging cardiac tissue

MOTS-c improves metabolic function in mice

Mitochondrial peptide MOTS-c regulates metabolic homeostasis

BPC-157 accelerates wound closure after alkali-burn injury

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance

Oxytocin modulates social behavior and emotional recognition

Selank modulates expression of genes related to neurotransmission in the frontal cortex

KPV peptide suppresses intestinal inflammation and mucosal injury

Incretin hormones regulate appetite and glucose metabolism

Antimicrobial peptides play critical roles in innate immunity

Bremelanotide increased sexual arousal response in clinical testing

Mitochondrial peptide SS-31 improves skeletal muscle energetics

NAD+ metabolism and aging pathways

Adipotide anti-obesity vascular targeting strategy: translational perspective

AOD-9604 review of clinical development and anti-obesity pharmacology

Tesofensine and metabolic regulation pathways

Thymosin alpha-1 immunomodulatory effects

KPV tripeptide anti-inflammatory effects in colitis models

BPC-157 nitric oxide system interaction and vascular protection

Selank affects monoamine metabolism and stress response pathways

SS-31 peptide protects against ischemia-reperfusion injury

Oxytocin effects on social cognition and bonding

Copper peptides and skin remodeling mechanisms

BPC-157 promotes healing of injured tendon in rat models

Copper peptides and tissue remodeling: role of GHK-Cu in skin repair

Selank effects on anxiety and memory processes in preclinical models

Adipotide and targeted apoptosis of adipose vasculature in obese primates

Oxytocin influences trust and social cognition in humans

Peptide regulation of dermal repair and collagen production

BPC-157 tendon-healing mechanisms in fibroblast outgrowth and FAK-paxillin signaling

Semax and neurotrophin-related signaling in ischemic and cognitive models

Stable gastric pentadecapeptide BPC-157 promotes angiogenesis and wound healing

Tesamorelin therapy reduces visceral adipose tissue in HIV lipodystrophy

Semax peptide neuroprotective effects in cerebral ischemia models

Tesamorelin reduces visceral fat in HIV lipodystrophy

Semax enhances BDNF signaling and neuroprotection after cerebral ischemia

IGF signaling integrates growth and metabolism in muscle physiology

Clinical effects of tesofensine on body weight and metabolic markers

Mitochondria-targeted peptide SS-31 improves cardiac mitochondrial function

Selank peptide modulation of anxiety and GABA signaling

Hexarelin protects the heart and stimulates GH release: a mechanistic review

Tesofensine produces sustained weight loss in obese subjects

Epitalon peptide and telomerase activation in aging models

Epitalon and telomere biology in aging research

Tesofensine modulates monoamine neurotransmitters affecting appetite

MK-677 metabolic and endocrine effects in healthy volunteers

Thymosin beta-4 improves cardiac repair after myocardial injury

Growth hormone-releasing hormone analog pharmacology and endocrine applications

Hexarelin and ghrelin receptor agonists increase pulsatile GH secretion

Thymosin beta-4 and tissue regeneration signaling pathways

Pinealon peptide influences neuronal gene expression

IGF-I and skeletal muscle hypertrophy mechanisms

AOD9604 and GH fragment peptides in obesity pharmacotherapy

CJC-1295, a long-acting GHRH analog, stimulates GH and IGF-1 secretion in adults

Somatropin treatment in adults with GH deficiency: meta-analysis of body composition outcomes

MK-677 improves bone density markers in elderly subjects

IGF-1 signaling in skeletal muscle hypertrophy

AOD-9604 effects on lipid metabolism in obesity

Growth hormone-releasing hormone analogs in adult endocrinology

Thymosin beta-4 improves cardiac repair after myocardial infarction

Pinealon peptide exhibits neuroprotective effects in aging brain models

Melanotan peptides and melanocortin signaling in sexual function

Growth hormone secretagogues and ghrelin receptor biology

Growth hormone fragment 176-191 and adipose metabolism in obesity models

Mechanisms of ghrelin receptor agonists on GH axis signaling

Thymosin Beta-4 promotes wound healing and angiogenesis

Melanotan peptides and melanocortin receptor pharmacology

Thymosin beta-4 promotes endothelial migration and angiogenesis

Melanotan II influences sexual arousal pathways via melanocortin signaling

Selective ghrelin receptor agonist MK-677 improves IGF-1 levels in GH-deficient adults

Melanotan II activates melanocortin receptors affecting pigmentation

Thymosin beta-4 regulates actin cytoskeleton and tissue repair signaling

AOD-9604 human growth hormone fragment reduces body fat in overweight adults

Ipamorelin, a selective growth hormone secretagogue, in human pituitary testing

Long-term administration of MK-677 increases fat-free mass in elderly adults

Ibutamoren improves sleep architecture and GH secretion

Hexarelin and growth hormone release in humans

Ibutamoren (MK-677) stimulates growth hormone secretion in healthy adults

GHRP peptides including hexarelin stimulate GH release

Recombinant human IGF-I in metabolic and anabolic physiology

Growth hormone therapy improves body composition in adults with GH deficiency

Delta sleep-inducing peptide and sleep physiology: experimental overview

Sermorelin growth hormone releasing hormone analog research

Sermorelin stimulates endogenous growth hormone release

Sermorelin and GHRH analogs in GH-deficient patients: early clinical evidence

DSIP: neurobiology and possible role in sleep regulation

GHK-Cu peptide stimulates collagen synthesis in skin fibroblasts

Copper peptide GHK-Cu stimulates collagen production in fibroblasts

DSIP peptide sleep modulation research

Delta sleep-inducing peptide studied for sleep-cycle modulation